Anti-prolactin Receptor Antibody LFA102

Known as: LFA102 
A neutralizing antibody against the prolactin receptor (PRLR) with potential antineoplastic activity. Upon administration, anti-prolactin receptor… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2016
0120122016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
In the era of precision medicine, the identification of new targets is a constant challenge to improve cancer therapy… (More)
Is this relevant?
2016
2016
LESSONS LEARNED Despite evidence for a role for prolactin signaling in breast and prostate tumorigenesis, a prolactin receptor… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2013
2013
Numerous lines of evidence suggest that the polypeptide hormone prolactin (PRL) may contribute to breast and prostate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2013
Review
2013
The prolactin (PRL)-prolactin receptor (PRLR) signaling complex has been implicated in the pathology of breast and prostate… (More)
  • figure 1
  • figure 2
Is this relevant?
2013
2013
The prolactin (PRL)–prolactin receptor (PRLR) signaling complex has been implicated in the pathology of breast and prostate… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2012
Review
2012
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Numerous lines of… (More)
  • table 1
Is this relevant?